EUVIMEDEUVIMED entdecken
Crossref

A Dual 5‐HT 7 Receptor Antagonist and Sodium Channel Inhibitor With Antidepressant‐ and Anxiolytic‐Like Activity and Reduced Hepatotoxicity

Anna Czopek iD, Katarzyna Wójcik-Pszczoła iD, Paulina Koczurkiewicz-Adamczyk, Michał Sapa iD, Krzysztof Kamiński iD, Grzegorz Satała iD, Andrzej J Bojarski iD, Agata Siwek, Małgorzata Wolak, Kinga Sałat iD

Archiv der Pharmazie · 2026

DOI: 10.1002/ardp.70366 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archiv der Pharmazie, 2026. Verfasst von Anna Czopek und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicinal Chemistry, Faculty of Pharmacy, Jagiellonian University Medical College, Kraków, Poland. Hauptthemen laut MEDLINE: Antidepressive Agents, Receptors, Serotonin, Anti-Anxiety Agents, Serotonin Antagonists. Die Arbeit nennt 45 Literaturangaben. Gefördert von: National Science Center Poland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The aim of this study was to characterize the pharmacological profile of a newly synthesized compound 5 ( R,S) −1‐(5‐{4‐[(1,1'‐biphenyl)‐2‐yl]piperazin‐1‐yl}pentyl)−3',4'‐dihydro‐2' H ‐spiro[imidazolidine‐4,1'‐naphthalene]‐2,5‐dione, designed as a dual‐acting ligand targeting the serotonin 5‐HT 7 receptor and voltage‐gated sodium channels. In vitro studies demonstrated that compound 5 exhibits high affinity for the 5‐HT 7 receptor (K i = 19 nM), comparable to the reference ligand LP‐211, and potent inhibition of sodium channels, markedly stronger than that of phenytoin. Functional assays confirmed that compound 5 acts as a 5‐HT 7 receptor antagonist (K b = 87 nM) with no detectable agonist activity. In addition, the compound showed negligible affinity for the serotonin transporter (SERT), indicating a favorable selectivity profile. Molecular docking studies revealed a stable binding mode of compound 5 within the orthosteric site of the 5‐HT 7 receptor, consistent with known GPCR interaction patterns. Modifications to compound 5 improved its safety by reducing hepatocytotoxicity in HepG2 cells. In vivo behavioral experiments demonstrated significant antidepressant‐like effects in the forced swim test and anxiolytic‐like effects in the four‐plate test in mice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antidepressive AgentsReceptors, SerotoninAnti-Anxiety AgentsSerotonin AntagonistsSodium ChannelsAnimalsHumansMolecular Docking SimulationStructure-Activity RelationshipMiceHep G2 CellsMaleDose-Response Relationship, DrugMolecular StructureLiver

Stichwörter der Autor:innen

5‐HT7 receptorsantidepressant‐like and anxiolytic‐like activitysodium channels inhibitorsspirohydantoin derivative

Substanzen

serotonin 7 receptorAntidepressive AgentsReceptors, SerotoninAnti-Anxiety AgentsSerotonin AntagonistsSodium Channels

Autor:innen und Institutionen

  • Department of Medicinal Chemistry, Faculty of Pharmacy, Jagiellonian University Medical College, Kraków, Poland.
  • Department of Pharmaceutical Biochemistry, Faculty of Pharmacy, Jagiellonian University Medical College, Krakow, Poland.
  • Department of Medicinal Chemistry, Maj Institute of Pharmacology, Polish Academy of Sciences, Kraków, Poland.
  • Department of Pharmacodynamics, Chair of Pharmacodynamics, Faculty of Pharmacy, Jagiellonian University Medical College, Kraków, Poland.

ORCID-Profile: Anna Czopek, Katarzyna Wójcik-Pszczoła, Michał Sapa, Krzysztof Kamiński, Grzegorz Satała, Andrzej J Bojarski, Kinga Sałat

Förderung

  • National Science Center Poland

Zitieren

APA

Czopek, A., Wójcik-Pszczoła, K., Koczurkiewicz-Adamczyk, P., Sapa, M., Kamiński, K., Satała, G., Bojarski, A. J., Siwek, A., Wolak, M., & Sałat, K. (2026). A Dual 5‐HT 7 Receptor Antagonist and Sodium Channel Inhibitor With Antidepressant‐ and Anxiolytic‐Like Activity and Reduced Hepatotoxicity. Archiv der Pharmazie. https://doi.org/10.1002/ardp.70366

Vancouver

Czopek A, Wójcik-Pszczoła K, Koczurkiewicz-Adamczyk P, Sapa M, Kamiński K, Satała G, et al. A Dual 5‐HT 7 Receptor Antagonist and Sodium Channel Inhibitor With Antidepressant‐ and Anxiolytic‐Like Activity and Reduced Hepatotoxicity. Archiv der Pharmazie. 2026. doi:10.1002/ardp.70366

BibTeX
@article{Czopek2026,
  author = {Czopek, Anna and Wójcik-Pszczoła, Katarzyna and Koczurkiewicz-Adamczyk, Paulina and Sapa, Michał and Kamiński, Krzysztof and Satała, Grzegorz and Bojarski, Andrzej J and Siwek, Agata and Wolak, Małgorzata and Sałat, Kinga},
  title = {A Dual 5‐HT 7 Receptor Antagonist and Sodium Channel Inhibitor With Antidepressant‐ and Anxiolytic‐Like Activity and Reduced Hepatotoxicity},
  journal = {Archiv der Pharmazie},
  year = {2026},
  doi = {10.1002/ardp.70366}
}
Kostenlos starten →